All the news Showing 10 of 696 articles from: Treatment issuesGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources COVID-19 pandemic led to a 30% drop in new hepatitis C treatments in the United States Keith Alcorn / 22 March 2022 Hepatitis C testing and treatment initiations in the United States dropped by 30% at the beginning of the COVID-19 pandemic in 2020 and treatment initiations did not recover to previous levels during ... Hepatitis C prevalence down by 40% since 2015 in England Keith Alcorn / 11 March 2022 The prevalence of hepatitis C in England fell by almost 40% between 2015 and 2020 and deaths due to the virus fell by 35% in the same period, the UK Health Security Agency ... Metabolic disorders cause liver damage in people with HIV more often than viral hepatitis in lower-income countries Keith Alcorn / 01 March 2022 Liver fibrosis in people with HIV in low- and middle-income countries was more often attributable to metabolic disorders than viral hepatitis, a six-country comparative study has found.The findings, presented last ... New cases of hepatitis C declining in people with HIV as access to treatment broadens Keith Alcorn / 21 February 2022 The availability of direct-acting antivirals has led to a 50% reduction in new cases of hepatitis among people with HIV in some high-income settings, a six-country study presented this week ... Prioritise harm reduction services to prevent hepatitis C re-infection, Scottish study finds Keith Alcorn / 24 January 2022 Limiting re-infection with hepatitis C in people who use drugs is most likely to be achieved by intensifying provision of sterile injecting equipment for people using needle and syringe programmes and increasing ... One in five new cases of hepatitis C in people who inject drugs due to unstable housing, modelling shows Keith Alcorn / 11 January 2022 Unstable housing may be responsible for up to one in five new infections with HIV or hepatitis C among people who inject drugs in the United Kingdom and the United States, a ... Three-drug regimen plus ribavirin cures the hardest-to-treat hepatitis C patients Keith Alcorn / 08 December 2021 People who have experienced failure of multiple courses of direct-acting antiviral treatment can be cured of hepatitis C with a combination of three direct-acting antivirals plus ribavirin, a review of heavily treatment-experienced patients ... Cognitive function improves after hepatitis C cure Keith Alcorn / 22 October 2021 Curing hepatitis C improves cognitive function, especially in older people already showing signs of cognitive impairment, a Spanish study has found. Cognitive impairment covers a wide spectrum of problems with memory, concentration, learning, attention ... Rapid hepatitis C treatment leads to high cure rate in young people who inject drugs Liz Highleyman / 12 October 2021 A simplified, same-day treatment model led to a higher cure rate compared with usual care for young people who inject drugs, according to research presented last week at the virtual IDWeek meeting. ... Addressing the Intertwined Opioid, HIV, and HCV Crises: Q&A with Rick Altice Yale School of Medicine / 20 September 2021 ← Prev12345...70Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Transmission and prevention Diagnosis and monitoring Disease course and symptoms HCV and coinfections Living with HCV Treatment issues Side effects Therapies Liver transplants Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive